Home » Topics » BioWorld Science

BioWorld Science
RSS

SciSparc signs agreement for phase IIa trial of SCI-110 for Alzheimer agitation

Feb. 18, 2021

Study may yield ways to harness bacterial antibiotic production

Feb. 18, 2021

AbFero receives funding for development of SP-420 for Parkinson's disease

Feb. 18, 2021

First patient dosed in U.S. phase II/III COVID-19 outpatient study of RHB-107

Feb. 18, 2021

N-803 plus BCG shows promise for treating NMIBC

Feb. 18, 2021

Highly phosphorylated GCase M-011 exhibits improved potential in Gaucher disease

Feb. 18, 2021

First patient dosed in phase I study of IkT-148009

Feb. 18, 2021

New anoctamin-1 potentiators synthesized at Enterprise Therapeutics

Feb. 18, 2021

Sichuan Haisco Pharmaceutical identifies kappa-opioid receptor agonist derivatives

Feb. 18, 2021

University of Texas, Axxam patent CX3CR1 and/or CX3CL1 agonists

Feb. 18, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...